ENVB vs. PPH
ENVB (Enveric Biosciences Inc) is a stock, while PPH (VanEck Pharmaceutical ETF) is Health & Biotech Equities fund tracking the MVIS US Listed Pharmaceutical 25 Index. Over the past 10 years, ENVB returned -74.71%/yr vs 7.99%/yr for PPH. Their 0.13 correlation means their historical movements had little consistent relationship.
Performance
ENVB vs. PPH - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ENVB achieves a -56.75% return, which is significantly lower than PPH's 8.50% return. Over the past 10 years, ENVB has underperformed PPH with an annualized return of -74.71%, while PPH has yielded a comparatively higher 7.99% annualized return.
ENVB
- 1D
- 9.79%
- 1M
- 8.28%
- 6M
- -46.05%
- YTD
- -56.75%
- 1Y
- -88.62%
- 3Y*
- -85.14%
- 5Y*
- -84.44%
- 10Y*
- -74.71%
- ALL TIME*
- -72.66%
PPH
- 1D
- -1.08%
- 1M
- -0.89%
- 6M
- 4.81%
- YTD
- 8.50%
- 1Y
- 33.42%
- 3Y*
- 13.78%
- 5Y*
- 10.23%
- 10Y*
- 7.99%
- ALL TIME*
- 5.76%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $156.43K | $152.33K | $428.69K | |
| $23.32M | $26.79M | $26.37M |
ENVB vs. PPH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ENVB Enveric Biosciences Inc | -56.75% | -94.37% | -72.43% | -37.50% | -95.53% | -37.16% | -34.51% | -48.17% | -94.37% | -52.38% |
PPH VanEck Pharmaceutical ETF | 8.50% | 22.00% | 8.05% | 6.95% | 2.64% | 17.79% | 5.49% | 19.39% | -5.89% | 15.23% |
Correlation
The correlation between ENVB and PPH is 0.06, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.06 |
Correlation (3Y) Balances recent behavior with more history. | 0.12 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.15 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.13 |
Correlation (All Time) Calculated using the full available price history since Jan 4, 2016 | 0.13 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ENVB vs. PPH — Risk / Return Rank
ENVB
PPH
ENVB vs. PPH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Enveric Biosciences Inc (ENVB) and VanEck Pharmaceutical ETF (PPH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ENVB | PPH | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.53 | ||
| Sortino ratioReturn per unit of downside risk | -4.05 | ||
| Omega ratioGain probability vs. loss probability | 0.88 | 1.35 | -0.47 |
| Calmar ratioReturn relative to maximum drawdown | -0.96 | 3.36 | -4.32 |
| Martin ratioReturn relative to average drawdown | -1.20 | 8.51 | -9.71 |
Loading charts...
Drawdowns
ENVB vs. PPH - Drawdown Comparison
The maximum ENVB drawdown since its inception was -100.00%, which is greater than PPH's maximum drawdown of -51.45%. Use the drawdown chart below to compare losses from any high point for ENVB and PPH.
Loading charts...
Drawdown Indicators
| ENVB | PPH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -100.00% | -51.45% | -48.55% |
Max Drawdown (1Y)Largest decline over 1 year | -92.70% | -10.76% | -81.94% |
Max Drawdown (3Y)Largest decline over 3 years | -99.75% | -18.06% | -81.69% |
Max Drawdown (5Y)Largest decline over 5 years | -100.00% | -20.26% | -79.74% |
Max Drawdown (10Y)Largest decline over 10 years | -100.00% | -29.70% | -70.30% |
Current DrawdownCurrent decline from peak | -100.00% | -2.79% | -97.21% |
Average DrawdownAverage peak-to-trough decline | -86.25% | -17.22% | -69.03% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 74.21% | 4.24% | +69.97% |
Volatility
ENVB vs. PPH - Volatility Comparison
Enveric Biosciences Inc (ENVB) has a higher volatility of 17.33% compared to VanEck Pharmaceutical ETF (PPH) at 6.53%. This indicates that ENVB's price experiences larger fluctuations and is considered to be riskier than PPH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ENVB | PPH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 17.33% | 6.53% | +10.80% |
Volatility (6M)Calculated over the trailing 6-month period | 100.97% | 13.52% | +87.45% |
Volatility (1Y)Calculated over the trailing 1-year period | 175.72% | 18.18% | +157.54% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 155.84% | 15.42% | +140.42% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 163.84% | 17.05% | +146.79% |
Dividends
ENVB vs. PPH - Dividend Comparison
ENVB has not paid dividends to shareholders, while PPH's dividend yield for the trailing twelve months is around 1.97%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ENVB Enveric Biosciences Inc | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
PPH VanEck Pharmaceutical ETF | 1.97% | 1.78% | 1.98% | 2.09% | 1.55% | 1.62% | 1.66% | 1.77% | 1.97% | 1.92% | 2.43% | 1.93% |
Frequently Asked Questions
ENVB and PPH have a correlation of 0.06, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ENVB has higher volatility (17.33%) compared to PPH (6.53%). In terms of maximum drawdown, ENVB dropped -100.00% vs PPH's -51.45%.
PPH currently has the higher Sharpe Ratio (2.02 vs -0.51), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ENVB and PPH
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer